Kenvue Inc. Common Stock vs NOV Inc. Common Stock — how do they compare? Kenvue Inc. Common Stock trades at $17.68 (market cap $34.06B), while NOV Inc. Common Stock trades at $18.97 (market cap $6.77B). The key difference: Kenvue Inc. Common Stock is far larger — about 5× NOV Inc. Common Stock's market cap, and Kenvue Inc. Common Stock pays the higher dividend (4.74%). Which is the better fit depends on your goals.
| KVUE | NOV | |
|---|---|---|
Market Cap | $34.06B | $6.77B |
Volume | 23,267,228 | 3,592,724 |
Sector | Consumer Staples | Energy |
52-Week High | $19.83 | $21.71 |
52-Week Low | $14.11 | $12.31 |
Enterprise Value | $41.56B | $7.93B |
Dividend Yield | 4.74% | 1.9% |
Typical Hold Time | — | 1 Days |
Trailing returns across standard periods
Latest headlines on both assets
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →NOV provides technology, equipment, and services for energy production. Its offerings support drilling, well construction, and production across oil, gas, renewables, and emerging energy markets.
Read more on NOV →